1203 related articles for article (PubMed ID: 22366769)
21. Neuropsychological correlates of the P300 in patients with Alzheimer's disease.
Lee MS; Lee SH; Moon EO; Moon YJ; Kim S; Kim SH; Jung IK
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():62-9. PubMed ID: 22940475
[TBL] [Abstract][Full Text] [Related]
22. The Spanish version of the Addenbrooke's Cognitive Examination - Revised (ACE-R) in subcortical ischemic vascular dementia.
Raimondi C; Gleichgerrcht E; Richly P; Torralva T; Roca M; Camino J; Manes F
J Neurol Sci; 2012 Nov; 322(1-2):228-31. PubMed ID: 22959102
[TBL] [Abstract][Full Text] [Related]
23. Patterns of neuropsychological impairment in Alzheimer's disease and mixed dementia.
Dong Y; Gan DZ; Tay SZ; Koay WI; Collinson SL; Hilal S; Venketasubramanian N; Chen C
J Neurol Sci; 2013 Oct; 333(1-2):5-8. PubMed ID: 23978422
[TBL] [Abstract][Full Text] [Related]
24. Neuropsychological comparison of Alzheimer's disease and dementia with lewy bodies.
Crowell TA; Luis CA; Cox DE; Mullan M
Dement Geriatr Cogn Disord; 2007; 23(2):120-5. PubMed ID: 17148939
[TBL] [Abstract][Full Text] [Related]
25. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
[TBL] [Abstract][Full Text] [Related]
26. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.
Acosta-Baena N; Sepulveda-Falla D; Lopera-Gómez CM; Jaramillo-Elorza MC; Moreno S; Aguirre-Acevedo DC; Saldarriaga A; Lopera F
Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
28. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
[TBL] [Abstract][Full Text] [Related]
29. [Clinical presentation of Moroccan cases with Alzheimer's disease].
El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
[TBL] [Abstract][Full Text] [Related]
30. Identification of responders and reactive domains to rivastigmine in Alzheimer's disease.
Frankfort SV; Appels BA; de Boer A; Tulner LR; van Campen JP; Koks CH; Beijnen JH; Schmand BA
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):545-51. PubMed ID: 17109476
[TBL] [Abstract][Full Text] [Related]
31. Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes.
Wicklund AH; Rademaker A; Johnson N; Weitner BB; Weintraub S
Alzheimer Dis Assoc Disord; 2007; 21(4):S70-8. PubMed ID: 18090428
[TBL] [Abstract][Full Text] [Related]
32. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X
J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
[TBL] [Abstract][Full Text] [Related]
33. Do cholinesterase inhibitors act primarily on attention deficit? A naturalistic study in Alzheimer's disease patients.
Bracco L; Bessi V; Padiglioni S; Marini S; Pepeu G
J Alzheimers Dis; 2014; 40(3):737-42. PubMed ID: 24577458
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
35. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
36. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
37. Neuropsychological performance in early and late onset Alzheimer's disease: comparisons in a memory clinic population.
Suribhatla S; Baillon S; Dennis M; Marudkar M; Muhammad S; Munro D; Spreadbury C; Lindesay J
Int J Geriatr Psychiatry; 2004 Dec; 19(12):1140-7. PubMed ID: 15526308
[TBL] [Abstract][Full Text] [Related]
38. Frontotemporal dementia: patient characteristics, cognition, and behaviour.
Diehl J; Kurz A
Int J Geriatr Psychiatry; 2002 Oct; 17(10):914-8. PubMed ID: 12325050
[TBL] [Abstract][Full Text] [Related]
39. The pattern and course of cognitive impairment in late-life depression.
Köhler S; Thomas AJ; Barnett NA; O'Brien JT
Psychol Med; 2010 Apr; 40(4):591-602. PubMed ID: 19656429
[TBL] [Abstract][Full Text] [Related]
40. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease.
Ala TA; Hughes LF; Kyrouac GA; Ghobrial MW; Elble RJ
Int J Geriatr Psychiatry; 2002 Jun; 17(6):503-9. PubMed ID: 12112173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]